PMID- 31023567
OWN - NLM
STAT- MEDLINE
DCOM- 20200708
LR  - 20200708
IS  - 1876-4738 (Electronic)
IS  - 0914-5087 (Linking)
VI  - 74
IP  - 4
DP  - 2019 Oct
TI  - Medium- and long-term follow-up of transcatheter closure of ruptured sinus of 
      Valsalva aneurysm in Central Europe population.
PG  - 381-387
LID - S0914-5087(19)30084-X [pii]
LID - 10.1016/j.jjcc.2019.03.012 [doi]
AB  - BACKGROUND: We aimed to evaluate medium- and long-term outcomes of transcatheter 
      closure (TC) of ruptured sinus of Valsalva aneurysm (RSVA), which is a rare and 
      mostly congenital heart disease. METHODS: Retrospective analysis included 23 
      patients (14 males) aged 15-79 years (y; 39.9+/-18.5) selected for TC of RSVA 
      between 2007 and 2017 in two tertiary centers in Poland and Ukraine. Fifteen 
      patients were in New York Heart Association (NYHA) class III or IV before TC; 5 
      patients had acquired RSVA after previous cardiac surgery. We applied 22 duct, 3 
      muscular, and 1 atrial septal Amplatzer or Amplatzer-like occluders by the 
      anterograde venous approach after arterio-venous loop creation in all but 1 
      patient. Mean follow-up conducted in outpatient clinic was 5.5+/-3.5 (1-11)y. 
      RESULTS: The procedure was successful in 19/23 patients (82.6%). Four procedures 
      were abandoned and the device percutaneously retrieved due to coronary artery 
      compression (1 patient), transient increase of aortic regurgitation (AR; 1 
      patients) or embolization (2 patients). New onset of significant AR was noted in 
      one of the latter patients after device removal. NYHA class improved in all 
      treated patients but 2, in whom it remained stable (p<0.05), with 10 patients in 
      class I. Three patients needed percutaneous re-intervention during follow-up 
      because of significant residual shunt in 1 and late recurrent RSVA in 2 patients. 
      The follow-up of the remaining patients was uneventful. Neither erosion, 
      embolization, new AR, nor death were observed. CONCLUSIONS: The percutaneous 
      closure of RSVA is a safe and effective method of treatment with good clinical 
      outcome. However, although not described previously, recurrent shunts after TC of 
      RSVA are possible and can be treated successfully with another transcatheter 
      intervention.
CI  - Copyright (c) 2019 Japanese College of Cardiology. Published by Elsevier Ltd. All 
      rights reserved.
FAU - Galeczka, Michal
AU  - Galeczka M
AD  - Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, 
      Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, 
      Poland. Electronic address: michalgaleczka@gmail.com.
FAU - Glowacki, Jan
AU  - Glowacki J
AD  - Department of Radiology and Radiodiagnostics, SMDZ in Zabrze, Medical University 
      of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland.
FAU - Yashchuk, Nataliia
AU  - Yashchuk N
AD  - Department of Interventional Cardiology for Congenital and Acquired Heart 
      Disease, National Amosov Institute, Kyiv, Ukraine.
FAU - Ditkivskyy, Igor
AU  - Ditkivskyy I
AD  - Department of Cardiovascular Surgery, National Amosov Institute, Kyiv, Ukraine.
FAU - Rojczyk, Dominika
AU  - Rojczyk D
AD  - Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, 
      Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, 
      Poland.
FAU - Knop, Mateusz
AU  - Knop M
AD  - Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, 
      Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, 
      Poland.
FAU - Smerdzinski, Sebastian
AU  - Smerdzinski S
AD  - Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, 
      Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, 
      Poland.
FAU - Cherpak, Bogdan
AU  - Cherpak B
AD  - Department of Interventional Cardiology for Congenital and Acquired Heart 
      Disease, National Amosov Institute, Kyiv, Ukraine.
FAU - Szkutnik, Malgorzata
AU  - Szkutnik M
AD  - Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, 
      Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, 
      Poland.
FAU - Bialkowski, Jacek
AU  - Bialkowski J
AD  - Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, 
      Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, 
      Poland.
FAU - Fiszer, Roland
AU  - Fiszer R
AD  - Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, 
      Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, 
      Poland.
FAU - Lazoryshynets, Vasyl
AU  - Lazoryshynets V
AD  - Department of Cardiovascular Surgery, National Amosov Institute, Kyiv, Ukraine.
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20190423
PL  - Netherlands
TA  - J Cardiol
JT  - Journal of cardiology
JID - 8804703
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aortic Rupture/*surgery
MH  - Cardiac Catheterization/adverse effects/*methods
MH  - Cardiac Surgical Procedures/adverse effects/*methods
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Poland/epidemiology
MH  - Postoperative Complications/epidemiology/etiology
MH  - Retrospective Studies
MH  - Sinus of Valsalva/*surgery
MH  - Treatment Outcome
MH  - Ukraine/epidemiology
MH  - Young Adult
OTO - NOTNLM
OT  - Congenital heart disease
OT  - Percutaneous intervention
OT  - Ruptured sinus of Valsalva aneurysm
OT  - Treatment outcome
EDAT- 2019/04/27 06:00
MHDA- 2020/07/09 06:00
CRDT- 2019/04/27 06:00
PHST- 2018/12/19 00:00 [received]
PHST- 2019/02/07 00:00 [revised]
PHST- 2019/03/14 00:00 [accepted]
PHST- 2019/04/27 06:00 [pubmed]
PHST- 2020/07/09 06:00 [medline]
PHST- 2019/04/27 06:00 [entrez]
AID - S0914-5087(19)30084-X [pii]
AID - 10.1016/j.jjcc.2019.03.012 [doi]
PST - ppublish
SO  - J Cardiol. 2019 Oct;74(4):381-387. doi: 10.1016/j.jjcc.2019.03.012. Epub 2019 Apr 
      23.